CoChat
Cited by 324

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Promotion of Collateral Growth by Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Coronary Artery Disease: A Randomized, Double-Blind, Placebo-Controlled Study

Seiler, Christian, Pohl, Tilmann, Wustmann, Kerstin, Hutter, Damian, Nicolet, Pierre-Alain, Windecker, Stephan, Eberli, Franz R., Meier, Bernhard · 2001 · Circulation

Abstract

Background Experimentally, activated macrophages have been documented to induce vascular proliferation. Methods and Results In 21 patients (age 74±9 years) with extensive coronary artery disease not eligible for coronary artery bypass surgery, the effect of granulocyte-macrophage colony-stimulating factor (GM-CSF, Molgramostim) on quantitatively assessed collateral flow was tested in a randomized, double-blind, placebo-controlled fashion. The study protocol consisted of an invasive collateral flow index (CFI) measurement immediately before intracoronary injection of 40 μg of GM-CSF (n=10) or placebo (n=11) and after a 2-week period with subcutaneous GM-CSF (10 μg/kg) or placebo, respectively. CFI was determined by simultaneous measurement of mean aortic pressure (P ao , mm Hg), distal coronary occlusive pressure (P occl , mm Hg; using intracoronary sensor guidewires), and central venous pressure (CVP, mm Hg): CFI=(P occl −CVP)/(P ao −CVP). CFI, expressing collateral flow during coronary occlusion relative to normal antegrade flow during vessel patency, changed from 0.21±0.14 to 0.31±0.23 in the GM-CSF group ( P <0.05) and from 0.30±0.16 to 0.23±0.11 in the placebo group ( P =NS). The treatment-induced difference in CFI was +0.11±0.12 in the GM-CSF group and -0.07±0.12 in the placebo group ( P =0.01). ECG signs of myocardial ischemia during coronary balloon occlusion occurred in 9 of 10 patients before and 5 of 10 patients after GM-CSF treatment ( P =0.04), whereas they were observed in 5 of 11 patients before and 8 of 11 patients after placebo ( P =NS). Conclusions This first clinical study investigating the potential of GM-CSF to improve collateral flow in patients with coronary artery disease documents its efficacy in a short-term administration protocol.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/hc4201.097835

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

Metadata

Authors
Seiler, C., Pohl, T., Wustmann, K., Hutter, D., Nicolet, P.-A., Windecker, S., Eberli, F. R., & Meier, B.
Venue
Circulation
Published
2001-10-23
Volume
104
Issue
17
Pages
2012-2017
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2054629742
Cited by
324
References
16
FWCI
23.60
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.